Insulin Lispro. The first rapidly acting analogue ... At present no reports on glulisine use in pregnancy are available. [53] Insulin Glargine. The first long-acting insulin analogue was approved ...

and in its Q3 results Sanofi said US revenues from Lantus were down 15.5% in the quarter to $1.123 billion. Admelog has also been approved in Europe as a biosimilar under the name Insulin lispro ...

Both studies met their primary endpoint by demonstrating that efsitora’s HbA1C reduction was non-inferior to that of insulin glargine and ... Humalog (insulin lispro), a fast-acting insulin ...